It's understandable that Indiana Pacers legend Reggie Miller might want to see his old team win the 2025 Eastern Conference Finals over the New York Knicks. However, it's hard to ignore how a ...

White House Deputy Chief of Staff Stephen Miller called out CNN's Pamela Brown's "lazy assumptions" regarding the Trump administration's executive power during an appearance on "The Situation Room ...

WICHITA — “I was mind blown. I was shocked.” Ryin Miller crossed the finish line with her hands on her face. She let out a huge smile before the line and immediately buried her face.

Democrats have little to be giddy about these days, but they took pleasure in taunting White House Deputy Chief of Staff Stephen Miller as Elon Musk made his White House exit with Miller’s wife ...

On May 29, JMP Securities Silvan Tuerkcan revised the firm’s view on Taysha Gene Therapies, Inc. (NASDAQ:TSHA), raising the price target from $5 to $6 while keeping a Market Outperform rating.

DAVENPORT, Iowa (KWQC) - Congresswoman Mariannette Miller-Meeks hosted an event for local supporters in Davenport on Thursday. The event was at the Rhythm City Casino, and Miller-Meeks was joined ...

Investing.com -- Shares of Taysha Gene Therapies (NASDAQ:TSHA) soared 19% today after the company announced pivotal trial design details for TSHA-102 in Rett Syndrome, which were enabled by IRSF ...

DALLAS, May 28, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus ...

Taysha Gene Therapies, Inc. DALLAS, May 28, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing ...

DALLAS, May 28, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV ...

Shares of Taysha Gene Therapies climbed after the company announced details of a planned trial for its treatment for Rett syndrome and filed for a secondary share offering. The stock rose 13% to $ ...

DALLAS - Taysha Gene Therapies, Inc. (NASDAQ: TSHA), a clinical-stage biotech company specializing in gene therapies for central nervous system diseases, with a current market capitalization of $ ...